Literature DB >> 4559173

Primary amoebic meningoencephalitis.

R J Duma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4559173     DOI: 10.3109/10408367209151325

Source DB:  PubMed          Journal:  CRC Crit Rev Clin Lab Sci        ISSN: 0590-8191


× No keyword cloud information.
  7 in total

1.  The invasive behaviour of Cryptococcus neoformans: a possibility of direct access to the central nervous system?

Authors:  N G Gomes; M Boni; C C Primo
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

2.  Experimental Acanthamoeba infections in mice pretreated with methylprednisolone or tetracycline.

Authors:  S M Markowitz; T Sobieski; A J Martinez; R J Duma
Journal:  Am J Pathol       Date:  1978-09       Impact factor: 4.307

3.  Animal model of human disease. Primary amebic meningoencephalitis, Naegleria meningoencephalitis, CNS protozoal infection.

Authors:  A J Martinez; E C Nelson; R J Duma
Journal:  Am J Pathol       Date:  1973-11       Impact factor: 4.307

4.  In vitro susceptibility of pathogenic Naegleria and Acanthamoeba speicies to a variety of therapeutic agents.

Authors:  R J Duma; R Finley
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

5.  Isolation of amoebae from edible mushrooms.

Authors:  J J Napolitano
Journal:  Appl Environ Microbiol       Date:  1982-07       Impact factor: 4.792

6.  Application of flow cytometry to studies of pathogenic free-living amoebae.

Authors:  L L Muldrow; R L Tyndall; C B Fliermans
Journal:  Appl Environ Microbiol       Date:  1982-12       Impact factor: 4.792

7.  Risk for transmission of Naegleria fowleri from solid organ transplantation.

Authors:  S L Roy; R Metzger; J G Chen; F R Laham; M Martin; S W Kipper; L E Smith; G M Lyon; J Haffner; J E Ross; A K Rye; W Johnson; D Bodager; M Friedman; D J Walsh; C Collins; B Inman; B J Davis; T Robinson; C Paddock; S R Zaki; M Kuehnert; A DaSilva; Y Qvarnstrom; R Sriram; G S Visvesvara
Journal:  Am J Transplant       Date:  2013-11-26       Impact factor: 8.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.